You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Infex candidate nominated for COV-X programme

Infex Therapeutics, a company focusing on anti-infectives, has revealed the nomination of a candidate for its COV-X programme.